Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 2/2012

01-06-2012 | Case Report

Mesenteric venous thrombosis secondary to an unsuspected JAK2 V617F-positive myeloproliferative disorder

Authors: M. G. Bourke, S. T. Martin, M. O’Dwyer, J. Hanaghan, F. Bennani, M. K. Barry

Published in: Irish Journal of Medical Science (1971 -) | Issue 2/2012

Login to get access

Abstract

Background

Mesenteric venous thrombosis (MVT) is a rare but potentially fatal cause of mesenteric ischaemia. It presents insidiously and often diagnosis is made at emergency surgery. In half of the cases MVT develops without a causative factor, while in cases in which a pro-thrombotic state is found to exist MVT may be the first clinically detected consequence of that state. The myeloproliferative disorders (MPD) are known to contribute to the development of pro-thrombotic states. Recently, the JAK2 V617F mutation has been associated with the MPDs.

Conclusion

We describe a case of MVT occurring secondary to an unsuspected MPD, in which the patient was subsequently found to carry this mutation. We highlight the necessity to screen for this mutation in cases of intra-abdominal thromboses so that appropriate systemic anticoagulation may be instituted, and the patient may be followed so as to detect the development of an overt MPD.
Literature
3.
go back to reference Baxter EJ, Scott EM, Campbell PJ et al (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365:1054–1061PubMed Baxter EJ, Scott EM, Campbell PJ et al (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365:1054–1061PubMed
4.
go back to reference Ihle JN, Gilliland DG (2007) JAK2: normal function and role in haematopoietic disorders. Curr Opin Gene Dev 17:8–14CrossRef Ihle JN, Gilliland DG (2007) JAK2: normal function and role in haematopoietic disorders. Curr Opin Gene Dev 17:8–14CrossRef
5.
go back to reference Vannuchi AM, Antonioli E, Guglielmelli P et al (2007) Clinical profile of homozygous JAK2 V617F mutation in patients with polycythemia vera or essential thrombocythemia. Blood 110:840–846CrossRef Vannuchi AM, Antonioli E, Guglielmelli P et al (2007) Clinical profile of homozygous JAK2 V617F mutation in patients with polycythemia vera or essential thrombocythemia. Blood 110:840–846CrossRef
Metadata
Title
Mesenteric venous thrombosis secondary to an unsuspected JAK2 V617F-positive myeloproliferative disorder
Authors
M. G. Bourke
S. T. Martin
M. O’Dwyer
J. Hanaghan
F. Bennani
M. K. Barry
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Irish Journal of Medical Science (1971 -) / Issue 2/2012
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-009-0331-7

Other articles of this Issue 2/2012

Irish Journal of Medical Science (1971 -) 2/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.